LYMPH™
Comprehensive genomic profiling for B Cell and T Cell lymphoma
Lymph™ analyses mutations and selected translocations in 121 key genes in B cell lymphoma and 103 key genes in T cell lymphoma by targeted DNA-sequencing (Lymph™–B/T D), or in combination with whole transcriptome mRNA sequencing (Lymph™–B/T DR) to detect a broader range of gene translocations and expression changes.
WHO IS IT FOR
LYMPH™ B D/DR
Patients with B cell lymphoma
LYMPH™ T D/DR
Patients with
- T lymphoblastic lymphoma (TLL)
- Angioimmunoblastic T cell lymphoma (AITL)
- Extranodal NK/T cell lymphoma (nasal type) (ENKTCL-NT)
- Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS)
- Anaplastic large cell lymphoma (ALCL)
SAMPLE TYPES
Tumor tissue (FFPE block/slides, or frozen tissue)
Fine needle biopsy
Liquid biopsy (plasma and cerebrospinal fluid)
Peripheral blood or bone marrow
LET’S ACCELERATE PRECISION CANCER CARE, TOGETHER.
Learn more about our products and services or contact us today to discuss how we can partner together.
